Methsuximide Capsule
Product Images NDC 70954-228

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Methsuximide (NDC 70954-228). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container (Container)

Label for Methsuximide Capsules, USP 300 mg by ANI Pharmaceuticals, Inc. The label states the prescription drug is in capsule form, oral route, with 100 capsules per container. It includes storage instructions, a warning to keep drugs out of reach of children, and advises pharmacists to dispense the medication guide to each patient. The NDC number 70954-228-10 and issuance date 11/2022 are shown.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of Methsuximide, showing its molecular bonds and functional groups, including a phenyl ring, amide group, and methyl substitutions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.